Evaluation of the treatment tradeoff method in rectal cancer patients: Is surgery preference related to outcome utilities?

Medical Decision Making

Volumn 28, Issue 6, 2008, Pages 888-898

  Bossema, Ercolie R ^a   Marijnen, Corrie A M ^a,b   Baas Thijssen, Monique C M ^a   Van De Velde, Cock J H ^a   Stiggelbout, Anne M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Patient preferences; Probability tradeoff; Time tradeoff; Treatment tradeoff; Utilities

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL EVALUATION; CLINICAL TRIAL; DATA BASE; FECES INCONTINENCE; HEALTH CARE UTILIZATION; HUMAN; OUTCOME ASSESSMENT; PATIENT DECISION MAKING; PREOPERATIVE TREATMENT; RECTUM CANCER; RISK FACTOR; STOMA; TREATMENT PLANNING; VALIDITY;

AGED; DECISION MAKING; DECISION SUPPORT SYSTEMS, CLINICAL; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FECAL INCONTINENCE; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; PATIENT SATISFACTION; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; SURGICAL STOMAS; TREATMENT OUTCOME;

EID: 57049102434     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X08317013     Document Type: Article

References (42)

1. Heald RJ, Smedh RK, Kald A., Sexton R., Moran BJ Abdominoperineal excision of the rectum-an endangered operation. Dis Colon Rectum. 1997 ; 40: 747-51.
2. Dahlberg M., Glimelius B., Graf W., Pahlman L. Preoperative irradiation affects functional results after surgery for rectal cancer. Dis Colon Rectum. 1998 ; 41: 543-51.
3. Bretagnol F., Troubat H., Laurent C., Zerbib F., Saric J., Rullier E. Long-term functional results after sphincter-saving resection for rectal cancer. Gastroeneterol Clin Biol. 2004 ; 28: 155-9.
4. Guren MG, Eriksen MT, Wiig JN, et al. Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer. Eur J Surg Oncol. 2005 ; 31: 736-42.
5. Lundby L., Krogh K., Jensen VJ, et al. Long-term anorectal dysfunction after postoperative radiotherapy for rectal cancer. Dis Colon Rectum. 2005 ; 48: 1343-52.
6. Peeters Kcmj, Van de Velde CJH, Leer JWH, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients-A Dutch ColoRectal Cancer Group Study. J Clin Oncol. 2005 ; 23: 6199-206.
7. Kienle P., Abend F., Dueck M., Abel U., Treiber M., Riedl S. Influence of intraoperative and postoperative radiotherapy on functional outcome in patients undergoing standard and deep anterior resection for rectal cancer. Dis Colon Rectum. 2006 ; 49: 557-67.
8. Pollack J., Holm T., Cedermark B., Holmström B., Mellgren A. Long-term effects of preoperative radiation therapy on anorectal function. Dis Colon Rectum. 2006 ; 49: 345-52.
9. Rullier E., Sebag-Montefiore D. Sphincter saving is the primary objective for local treatment of cancer of the lower rectum. Lancet Oncol. 2006 ; 7: 775-7.
10. Marijnen CAM, Van de Velde CJH, Putter H., et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol. 2005 ; 23: 1847-58.
11. Zolciak A., Bujko K., Kepka L., Oledzki J., Rutkowski A., Nowacki MP Abdominoperineal resection for rectal cancer: patient preferences before and after treatment. Colorectal Dis. 2006 ; 8: 575-80.
12. Audisio RA, Eiliberti A., Geraghty B., Anderoni B. Personalised surgery for rectal tumors: the patient's opinion counts. Support Care Cancer. 1997 ; 5: 17-21.
13. Llewellyn-Thomas HA Investigating patients' preferences for different treatment options. Can J Nurs Res. 1997 ; 29: 45-64.
14. Stiggelbout AM, De HaesJCJM. Patient preferences for cancer treatment: an overview of measurement approaches. J Clin Oncol. 2001 ; 19: 220-30.
15. O'Connor AMC, Boyd NF, Warde P., Stolbach L., Till JE Eliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation technique and treatment experience on preferences. J Chron Dis. 1987 ; 40: 811-8.
16. Singer PA, Tasch ES, Stocking C., Rubin S., Siegler M., Weichselbaum R. Sex or survival: trade-offs between quality and quantity of life. J Clin Oncol. 1991 ; 9: 328-34.
17. Levine MN, Gafni A., Markham B., MacFarlane D. A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer. Ann Intern Med. 1992 ; 117: 53-8.
18. Kiebert GM, Stiggelbout AM, Leer JW, Kievit J., De HaesJCJM. Test-retest reliabilities of two treatment-preference instruments in measuring utilities. Med Decis Making. 1993 ; 13: 133-40.
19. McQuellon RP, Muss HB, Hoffman SL, Russell G., Craven B., Yellen SB Patient preferences for treatment of metastatic breast cancer: a study of women with early-stage breast cancer. J Clin Oncol. 1995 ; 13: 858-68.
20. Sebban C., Browman G., Gafni A., et al. Design and validation of a bedside decision instrument to elicit a patient's preference concerning allogenic bone marrow transplantation in chronic myeloid leukemia. Am J Hematol. 1995 ; 48: 221-7.
21. Yellen SB, Cella DF Someone to live for: social well-being, parenthood status, and decision-making in oncology. J Clin Oncol. 1995 ; 13: 1255-64.
22. Elit LM, Levine MN, Gafni A., et al. Patients' preferences for therapy in advanced epithelial ovarian cancer: development, testing, and application of a bedside decision instrument. Gynecol Oncol. 1996 ; 62: 329-35.
23. Brundage MD, Davidson JR, Mackillop WJ Trading treatment toxicity for survival in locally advanced non-small cell lung cancer. J Clin Oncol. 1997 ; 15: 330-40.
24. Palda VA, Llewellyn-Thomas HA, Mackenzie RG, Pritchard KI, Naylor CD Breast cancer patients' attitudes about rationing postlumpectomy radiation therapy: applicability of trade-off methods to policy-making. J Clin Oncol. 1997 ; 15: 3192-200.
25. Lindley C., Vasa S., Sawyer WT, Winer EP Quality of life and preferences for treatment following systematic adjuvant therapy for early-stage breast cancer. J Clin Oncol. 1998 ; 16: 1380-7.
26. Brundage MD, Feldman-Stewart D., Cosby R., et al. Phase I study of a decision aid for patients with locally advanced non-small-cell lung cancer. J Clin Oncol. 2001 ; 19: 1326-35.
27. Brundage MD, Feldman-Stewart D., Cosby R., et al. Cancer patients' attitudes toward treatment options for advanced non-small cell lung cancer: implications for patient education and decision support. Patient Educ Couns. 2001 ; 45: 149-57.
28. Feldman-Stewart D., Brundage MD, Van Manen L. A decision aid for men with early stage prostate cancer: theoretical basis of a test by surrogate patients. Health Expect. 2001 ; 4: 221-34.
29. Jansen SJT, Kievit J., Nooij MA, et al. Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile ? Br J Cancer. 2001 ; 84: 1577-85.
30. Simes RJ, Coates AS Patient preferences for adjuvant chemotherapy for early breast cancer: how much benefit is needed ? J Natl Cancer Inst Monogr. 2001 ; 30: 146-52.
31. Donovan KA, Greene PG, Shuster JL, Partridge EE, Tucker DC Treatment preferences in recurrent ovarian cancer. Gynecol Oncol. 2002 ; 86: 200-11.
32. Wong RKS, Gafni A., Whelan T., Franssen E., Fung K. Defining patient-based minimal clinically important effect sizes: a study in palliative radiotherapy for painful unresectable pelvic recurrences from rectal cancer. Int J Radiat Oncol Biol Phys. 2002 ; 54: 661-9.
33. Couture J., Chan R., Bouharaoui F. Patient's preferences for adjuvant postoperative chemoradiation therapy in rectal cancer. Dis Colon Rectum. 2005 ; 48: 2055-60.
34. Duric VM, Fallowfield LJ, Saunders C., Houghton J., Coates AS, Stockler MR Patients' preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwile ? Br J Cancer. 2005 ; 93: 1319-23.
35. Duric VM, Stockler MR, Heritier S., et al. Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwile now ? Ann Oncol. 2005 ; 16: 1786-94.
36. Kapiteijn E., Marijnen CAM, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resect-able rectal cancer. N Engl J Med. 2001 ; 345: 638-46.
37. Bowling A., Ebrahim S. Handbook of Health Research Methods: Investigation, Measurement and Analysis. Berkshire (UK): Open University Press ; 2005.
38. O'Connor AM Effects of framing and level of probability on patients' preferences for cancer chemotherapy. J Clin Epidemiol. 1989 ; 42: 119-26.
39. Jansen SJ, Otten W., Stiggelbout AM Review of determinants of patients' preferences for adjuvant therapy in cancer. J Clin Oncol. 2004 ; 22 ; 3181-90.
40. Stiggelbout AM, De Vogel-Voogt E. Health state valuations: a framework for studying the gap between the imagined and the real. Value Health. In press.
41. Kahneman D., Diener E., Schwartz N. Well-being: The Foundations of Hedonic Psychology. New York: Russell Sage Foundation ; 1999.
42. Bossema ER, Stiggelbout AM, Baas-Thijssen MCM, Van de Velde CJH, Marijnen CAM Patients' preferences for low rectal cancer surgery. Eur J Clin Oncol. 2008 ; 34: 42-8.